Navigation Links
Herons persist in Chicago wetlands despite exposure to banned chemicals
Date:1/16/2008

Herons nesting in the wetlands of southeast Chicago are still being exposed to chemicals banned in the U.S. in the 1970s, a research team reports. The chemicals do not appear to be affecting the birds reproductive success, however.

The findings appear in the current issue of the Journal of Great Lakes Research.

University of Illinois veterinary biosciences scientist Jeff Levengood led the study. Levengood, a wildlife toxicologist at the Illinois Natural History Survey, said that chemicals banned 30 years ago for their deleterious effects on wildlife are still showing up in the offspring of black-crowned night-herons in a Chicago wetland.

The researchers found PCBs and DDE in the eggs of night-herons nesting in the wetlands abutting Lake Calumet, in southeast Chicago. The Lake Calumet wetlands are surrounded by industrial developments along Lake Michigan near the Illinois-Indiana border.

The research team included scientists from the U.S. Geological Survey, the Illinois Waste Management and Research Center, and Purdue and Duke universities.

PCBs (polychlorinated biphenyls) were commonly used in electrical transformers and other industrial applications until they were banned in 1977 because of their toxicity in the environment.

DDE is a metabolic by-product of DDT (dichlorodiphenyltrichloroethane), a pesticide banned in 1972 because it was observed to kill or disrupt the reproduction of birds and other wildlife. The DDT ban is believed to have reversed the dramatic decline in the American bald eagle and the peregrine falcon in the continental U.S.

The Lake Calumet birds appear to be picking up the contamination primarily from Lake Michigan by means of an invasive fish, the alewife.

Alewives harbor comparable levels of PCBs and DDE in their tissues, Levengood said. The spawning season of the alewife in Lake Michigan coincides with the nesting season of the night-herons.

The alewif
'/>"/>

Contact: Diana Yates
diya@uiuc.edu
217-333-5802
University of Illinois at Urbana-Champaign
Source:Eurekalert  

Page: 1 2 3

Related medicine news :

1. Investigators uncover intriguing clues to why persistent acid reflux sometimes turns into cancer
2. Comment Regarding Congregation for the Doctrine of Faith Clarification Concerning Nutrition and Hydration for Patients in a Persistent Vegetative State
3. Chronic infection persists by targeting stromal cell network in lymphoid organs
4. Statin Benefits Persist After Treatment Stops
5. Pursuing parenthood: Discourses of persistence
6. Meniscal damage and the development of persistent knee pain
7. Want to Raise a Fruit-and-Veggie Lover? Be Persistent
8. Miscarriage myths persist despite prevalence of medical information
9. Women persist in plastic surgery treatments that are not working, research says
10. Racial disparities persist in cancer care
11. Childrens Memorial Hospital in Chicago Announces $100 Million Gift from Philanthropist Ann Lurie
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Herons persist in Chicago wetlands despite exposure to banned chemicals
(Date:9/2/2014)... 2014 TCG, a leading government technology strategy ... one of the fastest-growing companies in America for the seventh ... was previously recognized in 2013, 2012, 2011, 2010, 2009, 2008, ... grown 86% from 2010 to 2013, ranking the company at ... in America - up 635 spots from 2013! More information ...
(Date:9/2/2014)... The Wm. Jennings Bryan Dorn Veterans Affairs ... hall meeting for Veterans and their families on September 24. ... to provide Veterans with valuable healthcare and benefit information,” said ... provide a forum where we can gather important input directly ... fair will be held 4:45 p.m. to 5:45 p.m. in ...
(Date:9/2/2014)... California, the percentage undergoing a double mastectomy increased substantially ... associated with a lower risk of death than breast-conserving ... September 3 issue of JAMA . The authors ... breast was associated with a higher risk of death ... Randomized trials have demonstrated similar survival for patients with ...
(Date:9/2/2014)... September 02, 2014 Medex Analytic ... of their corporate headquarters in Coral Springs, Fla. due ... exceeded our business development objectives for the 2014 year ... Herbst. “Our industry has requested a higher level of ... reviews. Medex has delivered, and the industry has responded.” ...
(Date:9/2/2014)... 2014 (HealthDay News) -- Two new studies further confirm ... 6-year-olds who were breast-fed have a lower risk of ... while the other finds a similar trend when it ... benefits of breast-feeding in the immediate newborn period," said ... in New York City. She was not involved in ...
Breaking Medicine News(10 mins):Health News:TCG One of the Fastest-Growing Companies in America – for the Eighth Time! 2Health News:Increase seen in use of double mastectomy 2Health News:Increase seen in use of double mastectomy 3Health News:Medex Analytic Services Announces New Location for Corporate Headquarters 2Health News:More Evidence Breast-Feeding Lowers Child's Risk of Infections, Allergies 2
... CareBETHESDA, Md., March 18 The Cystic Fibrosis Foundation ... leadership in improving the quality of care for people ... Quality Assurance (NCQA).The outlook for people with CF continues ... by the Foundation. In the 1950s, few children with ...
... 18 Medivation, Inc. (Nasdaq: MDVN ... permission from the U.S. Food and Drug Administration ... of MDV3100, its novel androgen receptor antagonist, in ... have failed docetaxel-based chemotherapy. The placebo-controlled, double-blind, ...
... inkjet printer technology, researchers say , , WEDNESDAY, March 18 ... mussels and printer inkjet technology, researchers say they,ve come ... greater precision, promote faster recovery and reduce scarring. , ... tissue together after a patient has surgery, a team ...
... protection, study finds, , , WEDNESDAY, March 18 (HealthDay News) -- ... glasses of beer or wine a day appear to have ... study suggests. , Moderate drinking has been associated with decreasing ... linked to increasing the risk for some cancers. And though ...
... Underserved by other ProvidersLOS ANGELES, March 18 ... Board: FVRL), which through its wholly-owned operating ... Personal Health Records ("PHRs") ( www.mymedicalrecords.com ) ... ( www.myesafedepositbox.com ), has entered into an ...
... March 18 Shamir Optical Industry Ltd. (Nasdaq: ... of innovative products and technology to the ophthalmic lens ... quarter and year ended December 31, 2008.For the quarter ... to $30.6 million for the fourth quarter of 2007. ...
Cached Medicine News:Health News:Cystic Fibrosis Foundation to Receive Prestigious Health Care Award 2Health News:Medivation Receives FDA Permission to Initiate Phase 3 Trial of MDV3100 in Castration-Resistant Prostate Cancer 2Health News:Medivation Receives FDA Permission to Initiate Phase 3 Trial of MDV3100 in Castration-Resistant Prostate Cancer 3Health News:Medivation Receives FDA Permission to Initiate Phase 3 Trial of MDV3100 in Castration-Resistant Prostate Cancer 4Health News:Mussel-Based Glue May Make Surgery Safer 2Health News:A Little Drink May Be Good for Your Bones 2Health News:A Little Drink May Be Good for Your Bones 3Health News:MMR Information Systems Offers First Bilingual Personal Health Record Through The Latino Coalition 2Health News:MMR Information Systems Offers First Bilingual Personal Health Record Through The Latino Coalition 3Health News:MMR Information Systems Offers First Bilingual Personal Health Record Through The Latino Coalition 4Health News:Shamir Optical Industry Ltd. Reports Fourth Quarter and Year-End 2008 Results 2Health News:Shamir Optical Industry Ltd. Reports Fourth Quarter and Year-End 2008 Results 3Health News:Shamir Optical Industry Ltd. Reports Fourth Quarter and Year-End 2008 Results 4Health News:Shamir Optical Industry Ltd. Reports Fourth Quarter and Year-End 2008 Results 5Health News:Shamir Optical Industry Ltd. Reports Fourth Quarter and Year-End 2008 Results 6Health News:Shamir Optical Industry Ltd. Reports Fourth Quarter and Year-End 2008 Results 7Health News:Shamir Optical Industry Ltd. Reports Fourth Quarter and Year-End 2008 Results 8Health News:Shamir Optical Industry Ltd. Reports Fourth Quarter and Year-End 2008 Results 9
(Date:9/2/2014)... , Sept. 2, 2014  Ameritox SM , the ... Deadly Trend: Prescription Drugs to Heroin," a research report ... heroin abuse, and examines deadly trends that have created ... here . The report is ... patients prescribed opioids. It examines five trends that distinguish ...
(Date:9/2/2014)... September 2, 2014 ... ESC-Kongress 2014 präsentierte GARFIELD-AF-Register bietet einen ... von schlaganfallgefährdeten Patienten in der klinischen ... Daten der nahezu 12.500 ... und unabhängigen Forschungsinitiative zur Untersuchung von ...
(Date:9/2/2014)... , Registry provides new insights ... and treatment satisfaction [ 1 ] ...        (Photo: http://photos.prnewswire.com/prnh/20140902/703596 ... Barcelona, Spain : Daiichi Sankyo today ... events-European Registry in Atrial Fibrillation (PREFER in AF), revealing ...
Breaking Medicine Technology:Ameritox Research Report Reveals Pain Patients' Role in Current Heroin Epidemic 2Daten aus dem globalen Register zur Behandlung von Vorhofflimmern zeigen, dass antithrombotische Wirkstoffe zur Verhinderung von Schlaganfällen nicht optimal genutzt werden 2Daten aus dem globalen Register zur Behandlung von Vorhofflimmern zeigen, dass antithrombotische Wirkstoffe zur Verhinderung von Schlaganfällen nicht optimal genutzt werden 3Daten aus dem globalen Register zur Behandlung von Vorhofflimmern zeigen, dass antithrombotische Wirkstoffe zur Verhinderung von Schlaganfällen nicht optimal genutzt werden 4Daten aus dem globalen Register zur Behandlung von Vorhofflimmern zeigen, dass antithrombotische Wirkstoffe zur Verhinderung von Schlaganfällen nicht optimal genutzt werden 5Daten aus dem globalen Register zur Behandlung von Vorhofflimmern zeigen, dass antithrombotische Wirkstoffe zur Verhinderung von Schlaganfällen nicht optimal genutzt werden 6Daten aus dem globalen Register zur Behandlung von Vorhofflimmern zeigen, dass antithrombotische Wirkstoffe zur Verhinderung von Schlaganfällen nicht optimal genutzt werden 7Daten aus dem globalen Register zur Behandlung von Vorhofflimmern zeigen, dass antithrombotische Wirkstoffe zur Verhinderung von Schlaganfällen nicht optimal genutzt werden 8Daten aus dem globalen Register zur Behandlung von Vorhofflimmern zeigen, dass antithrombotische Wirkstoffe zur Verhinderung von Schlaganfällen nicht optimal genutzt werden 9Daten aus dem globalen Register zur Behandlung von Vorhofflimmern zeigen, dass antithrombotische Wirkstoffe zur Verhinderung von Schlaganfällen nicht optimal genutzt werden 10Daten aus dem globalen Register zur Behandlung von Vorhofflimmern zeigen, dass antithrombotische Wirkstoffe zur Verhinderung von Schlaganfällen nicht optimal genutzt werden 11One Year Data from the PREFER in AF Registry Show Significant Changes in Atrial Fibrillation (AF) Management in Europe and Implementation of Clinical Guidelines 2One Year Data from the PREFER in AF Registry Show Significant Changes in Atrial Fibrillation (AF) Management in Europe and Implementation of Clinical Guidelines 3One Year Data from the PREFER in AF Registry Show Significant Changes in Atrial Fibrillation (AF) Management in Europe and Implementation of Clinical Guidelines 4One Year Data from the PREFER in AF Registry Show Significant Changes in Atrial Fibrillation (AF) Management in Europe and Implementation of Clinical Guidelines 5One Year Data from the PREFER in AF Registry Show Significant Changes in Atrial Fibrillation (AF) Management in Europe and Implementation of Clinical Guidelines 6One Year Data from the PREFER in AF Registry Show Significant Changes in Atrial Fibrillation (AF) Management in Europe and Implementation of Clinical Guidelines 7One Year Data from the PREFER in AF Registry Show Significant Changes in Atrial Fibrillation (AF) Management in Europe and Implementation of Clinical Guidelines 8
... VANCOUVER, June 21, 2007 /PRNewswire-FirstCall/ - Biotech,Holdings reports ... diabetes drug its support in an overview of,diabetic ... Diabetes,Hoy, the Diabetic Federation's scientific and medical magazine ... of diabetic drugs, written by Dr. Roberto Cepeda,Gonzalez, ...
... -- Orexigen(TM),Therapeutics, Inc. , a biopharmaceutical company ... disorders with an initial focus,on obesity, today ... its lead obesity product candidate Contrave(TM) and ... fat, serum,cholesterol, and triglycerides) and insulin-resistance. The,findings ...
Cached Medicine Technology:Diabetes drug supported by Mexican Diabetes Federation 2Diabetes drug supported by Mexican Diabetes Federation 3Orexigen Therapeutics to Present Data on Contrave Impact on,Visceral Fat and Insulin Resistance at American Diabetes,Association 67th Scientific Sessions in Chicago June 23 2Orexigen Therapeutics to Present Data on Contrave Impact on,Visceral Fat and Insulin Resistance at American Diabetes,Association 67th Scientific Sessions in Chicago June 23 3
... with built-in bags as in a suspension file ... without contacting the ethylene glycol and without having ... ensures easy handling and maximum surface freezing concurrently ... the relatively hot air under the lid does ...
... UL Listed, CSA Certified, CE ... safely store single donor, fresh ... are standard. Cold wall refrigeration ... foamed-inplace polyurethane insulation for ultimate ...
... self-contained freezer complying with Australian Standard AS3864-1997 ... finish is grey colorbond steel with a ... to a 40-litre capacity polished stainless steel ... gasket contacting a heated top fascia. A ...
... Designed for ease of use and ... has smooth edges for comfort and is ... one-size-fits-all to a perfect fit. For hard ... a trach collar to your specifications. Don't ...
Medicine Products: